The latest board meeting for Lyell Immunopharma Inc took place on 11 Mar 2026, for the purpose of Lyell Immunopharma Inc Annual Report for 2025See details
Lyell Immunopharma Inc has a share price target of US$ 31, revenue growth forecast of -33.3%, and profit growth estimate of 47.7% for FY25, based on top 4 analyst calls.